 BOONTON, N.J., June 7, 2021 PRNewswire -- Enteris BioPharma, Inc., a biotechnology company developing innovative drug products based on its proprietary delivery technologies, and a wholly-owned subsidiary of SWK Holdings Corporation Nasdaq: SWKH, today announced that the company is participating in BIO Digital 2021. 